Joyce Thompson

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

David Cunningham, Ian Chau, Deborah Stocken et al. · Journal of Clinical Oncology · 2009 · 816 citations · Full text

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

Susan Dutton, David Ferry, Jane Blazeby et al. · The Lancet Oncology · 2014 · 329 citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +6

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Ronald B. Natale, Sumitra Thongprasert, F. Anthony Greco et al. · Journal of Clinical Oncology · 2011 · 296 citations

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial

Derek Alderson, David Cunningham, Matthew Nankivell et al. · The Lancet Oncology · 2017 · 219 citations · Full text

Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study

Lucio Crinò, Federico Cappuzzo, Petr Zatloukal et al. · Journal of Clinical Oncology · 2008 · 217 citations